Acurx pharmaceuticals to participate in the 2022 virtual growth conference presented by maxim group llc and hosted by m-vest on march 28-30, 2022 from 9:00 a.m. - 5:00 p.m.

Staten island, n.y., march 16, 2022 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that company's president & ceo, david p.
ACXP Ratings Summary
ACXP Quant Ranking